Table 1.
Treatment | CD20 expression (fold change) |
|
---|---|---|
Raji (at 12 h) | Daudi (at 20 h) | |
Control | 1 | 1 |
Vitamin C (1 μg/ml, 1 h) | 1 | 1 |
Amifostine (0.1 μg/ml, 1 h) | 1 | 1 |
H2O2 (1 μM) | 1.65±0.14* | 1.58±0.11* |
Vitamin C (1 μg/ml, 1 h)+H2O2 (1 μM) | 1.13±0.06# | 1.1±0.08# |
Radiation (0.5 Gy) | 2.2±0.25* | 1.8±0.3* |
Vitamin C (1 μg/ml, 1 h)+radiation (0.5 Gy) | 2.25±0.35* | 2.1±0.2* |
Amifostine+H2O2 | 1.1±0.073## | 0.94±0.08## |
Amifostine+radiation (0.5 Gy) | 0.9±0.2### | 1.2±0.15### |
Maximum CD20 expression varies from 12 to 20 h, depending on the cell type. Modulation of H2O2-or radiation-(0.5 Gy) induced CD20 expression using antioxidants (amifostine or vitamin C) was measured as described under Materials and methods. Cell-surface CD20 expression was measured by flow cytometry at 12 and 20 h for Raji and Daudi cells, respectively. All results are from three independent experiments and expressed as fold change in expression of CD20±SD.
p<0.05 for control vs radiation or H2O2.
p<0.05 for H2O2 vs vitamin C+H2O2.
p<0.5 for H2O2 vs amifostine+H2O2.
p<0.05 for 0.5 Gy vs amifostine+0.5 Gy.